Background: Escalating pyrethroid resistance in malaria vectors highlights the urgency of implementing new control tools incorporating non-pyrethroid molecules. Here, using DNA-based metabolic resistance markers, we assessed the efficacy of the dual active ingredients net Royal Guard against pyrethroids-resistant malaria vectors in Cameroon, establishing its long-term impact on mosquitoes' life traits after exposure.
Results: Cone assays revealed low efficacy of Royal Guard against field Anopheles populations. However, analysis of the survival curves revealed that unexposed mosquitoes lived longer (11.4 ± 0.4 days) than those exposed to Royal Guard (7.9 ± 0.2 days) (χ = 6; P = 0.05), indicating that despite the lower immediate mortality observed against resistant mosquitoes, there is a long-term effect on Anopheles funestus longevity. High blood-feeding inhibition rate was observed (44-80% versus 11-41%), indicating that this net has a negative impact on blood meal intake. Additionally, female mosquitoes exposed to this net exhibited a 25% reduction in oviposition, 18.30% reduction in fecundity, 8.10% reduction in offspring, and a 74.74% infertility rate compared to the control. Genotyping of key resistance markers revealed that, metabolic markers and L1014F-Kdrw are associated with the reduced efficacy observed, with homozygote-resistant mosquitoes significantly more able to survive and live longer after exposure than homozygote-susceptible mosquitoes (odds ratio = 15.79; confidence interval = 5.35-43.27; P < 0.0001).
Conclusion: This study revealed that although pyrethroid-resistant mosquitoes have higher ability to survive and live longer after exposure to Royal Guard, this net significantly affects their lifespan, blood-feeding ability and interestingly reduces their fecundity/fertility. © 2025 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ps.8615 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Escalating pyrethroid resistance in malaria vectors highlights the urgency of implementing new control tools incorporating non-pyrethroid molecules. Here, using DNA-based metabolic resistance markers, we assessed the efficacy of the dual active ingredients net Royal Guard against pyrethroids-resistant malaria vectors in Cameroon, establishing its long-term impact on mosquitoes' life traits after exposure.
Results: Cone assays revealed low efficacy of Royal Guard against field Anopheles populations.
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration.
JAMA Cardiol
January 2025
National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom.
Importance: Patients with transthyretin (ATTR) cardiac amyloid infiltration are increasingly diagnosed at earlier disease stages with no heart failure (HF) symptoms and a wide range of cardiac amyloid infiltration.
Objective: To characterize the clinical phenotype and natural history of asymptomatic patients with ATTR cardiac amyloid infiltration.
Design, Setting, And Participants: This cohort study analyzed data of all patients at 12 international centers for amyloidosis from January 1, 2008, through December 31, 2023.
Correction: HELLO: a protocol for a cluster randomized controlled trial to enhance interpersonal relationships and team cohesion among ICU healthcare professionals.
Intensive Care Med Exp
January 2025
Department of Biomedical Sciences, Humanitas University, Via Levi Montalcini, Pieve Emanuele, MI; 2IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Management of metastatic colorectal cancer: consensus in the Gulf Cooperation Council countries.
Ther Adv Med Oncol
January 2025
Tawam Hospital, po box 15254, Al Ain, United Arab Emirates.
Colorectal cancer (CRC) represents a major public health challenge globally, particularly in the Gulf Cooperation Council (GCC) countries, where it is identified as the second most prevalent form of cancer. Despite advancements in management strategies, tailored guidelines specific to the Gulf region are lacking. This paper presents consensus recommendations developed by a panel of experts from the GCC countries to address this gap.
View Article and Find Full Text PDFPropensity Score Analysis of Possible Medication Effects on Outcomes in Patients With Systemic Right Ventricles.
JACC Adv
January 2025
Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.
Background: Patients with systemic right ventricle (SRV), either d-transposition of the great arteries following an atrial switch procedure or congenitally corrected transposition of the great arteries, develop severe right ventricular dysfunction, prompting appropriate medical therapy. However, the efficacy of beta-blockers and angiotensin receptor blockers or angiotensin-converting enzyme inhibitors (ACEI) in SRV patients is unproven.
Objectives: The objective of this study was to determine the effects of ACEI/ARB and beta-blockers on outcomes in SRV patients after accounting for likely cofounders affecting their use.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!